Analysts: New CEO Could Boost Microsoft and 3 More Research Notes to Explore
Microsoft (NASDAQ:MSFT): BMO Capital increased its price target on Microsoft to $37 from $34 after the company announced the resignation of CEO Steve Ballmer, as the firm thinks a new CEO could significantly boost the company. However, the firm keeps a Market Perform rating on the stock, based on valuation.
Teva Pharmaceuticals (NYSE:TEVA): Buckingham recommends reducing Teva positions on its current strength, as the firm does not expect turnaround efforts and R&D moves to pay off until beyond 2015. The shares are Neutral rated with a $40 price target.
Safeway (NYSE:SWY): UBS believes Safeway could carry out a leveraged buyout offer for $28 per share if the company does not buy back $2 billion of its shares. However, the firm is not convinced that Safeway’s Ebitda has stabilized, and it lowered its estimates. UBS keeps a $20 price target and Sell rating on the stock.
Magnum Hunter (NYSE:MHR): RW Baird believes there are many upcoming catalysts for Magnum Hunter, including the Utica shale results, a potential Utica joint venture, and noncore asset monetizations in the near term. The firm maintains its Outperform rating and $6 price target.
Investing Insights: How Will Microsoft Perform After Recent News?